Both in Pharmaceuticals
Innovator U.S. Equity Ultra Buffer ETF - November vs AB Corporate Bond ETF
Over the past year UNOV returned +10.0% and EYEG returned −7.0%; their daily moves had a correlation of 0.38.
UNOV +10.0% EYEG −7.0%Growth of $1, one year, split-adjusted
| Metric | UNOV | EYEG |
|---|---|---|
| Price | $41.63 | $33.54 |
| Market cap | $111.4M | $26.8M |
| Today | −0.12% | −0.67% |
| 1 month | 0.0% | +0.1% |
| 6 months | +4.5% | −4.7% |
| Year to date | +9.4% | −6.2% |
| 1 year | +10.0% | −7.1% |
| Revenue growth (YoY) | −19.3% | — |
| Gross margin | 68.5% | — |
| Net margin | 11.4% | — |
| P/E (TTM) | 29.7× | — |
| Price / sales | 3.3× | — |
| Net cash | $2.7M | $16.8M |
| Dividend yield | — | 5.22% |
| Volatility (60d) | 7.0% | 5.5% |
| Short % of float | — | — |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).